{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:13:36Z","timestamp":1783062816569,"version":"3.54.6"},"reference-count":74,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.12898","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T06:36:52Z","timestamp":1748500612000},"page":"1-10","source":"Crossref","is-referenced-by-count":1,"title":["Successful surgical management of a patient with osteoradionecrosis of the jaw with RET fusion\u2011positive advanced thyroid cancer: A case report"],"prefix":"10.3892","volume":"30","author":[{"given":"Taku","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichiro","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Munekata","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Itagaki","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido 060\u20118638, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kanayama","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Vascular Biology and Molecular Pathology, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"key20250710122401_b1-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1200\/JCO.23.02750","article-title":"Prevention and management of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy: ISOO-MASCC-ASCO guideline","volume":"42","author":"Peterson","year":"2024","journal-title":"J Clin Oncol"},{"key":"key20250710122401_b2-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00000421-200204000-00013","article-title":"Osteoradionecrosis of the mandible: Scientific basis for clinical staging","volume":"25","author":"Schwartz","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"key20250710122401_b3-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00520-010-0898-6","article-title":"Osteoradionecrosis in cancer patients: The evidence base for treatment-dependent frequency, current management strategies, and future studies","volume":"18","author":"Peterson","year":"2010","journal-title":"Support Care Cancer"},{"key":"key20250710122401_b4-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/idj.12318","article-title":"Osteoradionecrosis of the jaws: Definition, epidemiology, staging and clinical and radiological findings. A concise review","volume":"68","author":"Chronopoulos","year":"2018","journal-title":"Int Dent J"},{"issue":"lgz006","key":"key20250710122401_b5-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgz006","article-title":"Research frontiers in oral toxicities of cancer therapies: Osteoradionecrosis of the jaws","volume":"2019","author":"Spijkervet","year":"2019","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key20250710122401_b6-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.oooo.2024.04.008","article-title":"The incidence of osteoradionecrosis of the jaws in oral cavity cancer patients treated with intensity-modulated radiotherapy: A systematic review and meta-analysis","volume":"138","author":"de Almeida-Silva","year":"2024","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"key20250710122401_b7-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/0284186X.2019.1643037","article-title":"Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: Risk factors and dose-volume correlations","volume":"58","author":"Aarup-Kristensen","year":"2019","journal-title":"Acta Oncol"},{"key":"key20250710122401_b8-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.bjoms.2020.10.006","article-title":"Timing of dental extractions in patients undergoing radiotherapy and the incidence of osteoradionecrosis: A systematic review and meta-analysis","volume":"59","author":"Beaumont","year":"2021","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key20250710122401_b9-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jds.2021.10.019","article-title":"Risk factors for osteoradionecrosis of the jaw in patients with oral or oropharyngeal cancer: Verification of the effect of tooth extraction before radiotherapy using propensity score matching analysis","volume":"17","author":"Kojima","year":"2022","journal-title":"J Dent Sci"},{"key":"key20250710122401_b10-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bjoms.2021.02.011","article-title":"Health related quality of life and patient concerns in patients with osteoradionecrosis","volume":"59","author":"Chieng","year":"2021","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key20250710122401_b11-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.radonc.2021.11.021","article-title":"Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1","volume":"166","author":"Forner","year":"2022","journal-title":"Radiother Oncol"},{"key":"key20250710122401_b12-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/scd.12759","article-title":"Pentoxifylline and tocopherol for prevention of osteoradionecrosis in patients who underwent oral surgery: A clinical audit","volume":"43","author":"Lombardi","year":"2023","journal-title":"Spec Care Dentist"},{"key":"key20250710122401_b13-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.anorl.2013.11.006","article-title":"Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results","volume":"131","author":"Robard","year":"2014","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"key20250710122401_b14-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1200\/JCO.2004.09.006","article-title":"Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized, placebo-controlled, double-blind trial from the ORN96 study group","volume":"22","author":"Annane","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20250710122401_b15-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.otohns.2009.03.013","article-title":"Analysis of outcomes of vascularized flap reconstruction in patients with advanced mandibular osteoradionecrosis","volume":"141","author":"Alam","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key20250710122401_b16-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hed.21537","article-title":"Free flap reconstruction of osteoradionecrosis of the mandible: A 10-year review and defect classification","volume":"33","author":"Baumann","year":"2011","journal-title":"Head Neck"},{"key":"key20250710122401_b17-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.ijom.2019.06.007","article-title":"The value of reconstructive surgery in the management of refractory jaw osteoradionecrosis: A single-center 10-year experience","volume":"48","author":"Bettoni","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"e000172","key":"key20250710122401_b18-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: Challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"issue":"1","key":"key20250710122401_b19-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02228-x","article-title":"Comprehensive genomic profiling for oncological advancements by precision medicine","volume":"41","author":"Pankiw","year":"2023","journal-title":"Med Oncol"},{"issue":"e0264138","key":"key20250710122401_b20-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264138","article-title":"Clinical and analytical validation of FoundationOne\u00aeCDx, a comprehensive genomic profiling assay for solid tumors","volume":"17","author":"Milbury","year":"2022","journal-title":"PLoS One"},{"key":"key20250710122401_b21-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/hed.10171","article-title":"Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy","volume":"25","author":"Notani","year":"2003","journal-title":"Head Neck"},{"issue":"102","key":"key20250710122401_b22-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20250710122401_b23-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/cam4.604","article-title":"Parity and thyroid cancer risk: A meta-analysis of epidemiological studies","volume":"5","author":"Zhu","year":"2016","journal-title":"Cancer Med"},{"key":"key20250710122401_b24-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ecl.2007.04.004","article-title":"Papillary thyroid cancer: Monitoring and therapy","volume":"36","author":"Tuttle","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key20250710122401_b25-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","article-title":"Thyroid cancer: Incidence and mortality trends in China, 2005-2015","volume":"68","author":"Wang","year":"2020","journal-title":"Endocrine"},{"key":"key20250710122401_b26-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/jso.20697","article-title":"Treatment of thyroid cancer based on risk groups","volume":"94","author":"Shaha","year":"2006","journal-title":"J Surg Oncol"},{"issue":"4295","key":"key20250710122401_b27-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174295","article-title":"Diagnostic and prognostic performance of liquid biopsy-derived exosomal microRNAs in thyroid cancer patients: A systematic review and meta-analysis","volume":"13","author":"Toraih","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20250710122401_b28-ETM-30-2-12898","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0019-509X.12352","article-title":"Isolated submandibular gland metastasis from an occult papillary thyroid cancer","volume":"41","author":"Sarda","year":"2004","journal-title":"Indian J Cancer"},{"key":"key20250710122401_b29-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1259\/dmfr\/30751894","article-title":"Isolated submandibular metastasis from a contralateral thyroid papillary microcarcinoma: An unusual case","volume":"38","author":"Davies","year":"2009","journal-title":"Dentomaxillofac Radiol"},{"key":"key20250710122401_b30-ETM-30-2-12898","doi-asserted-by":"crossref","first-page":"836","DOI":"10.18203\/issn.2454-5929.ijohns20181881","article-title":"Right submandibular gland metastasis from an occult papillary thyroid cancer","volume":"4","author":"Radia","year":"2018","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"issue":"131","key":"key20250710122401_b31-ETM-30-2-12898","article-title":"Occult metastatic papillary thyroid carcinoma presenting as submandibular mass: An unusual case","volume":"9","author":"Mittal","year":"2018","journal-title":"Int J Head Neck Surg"},{"key":"key20250710122401_b32-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jcu.22821","article-title":"Thyroid carcinoma metastasizing to the submandibular gland: Sonographic findings","volume":"48","author":"Golant","year":"2020","journal-title":"J Clin Ultrasound"},{"key":"key20250710122401_b33-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.13969","article-title":"Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study","volume":"110","author":"Sunami","year":"2019","journal-title":"Cancer Sci"},{"key":"key20250710122401_b34-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/pin.13023","article-title":"Multiplex gene-panel testing for lung cancer patients","volume":"70","author":"Yatabe","year":"2020","journal-title":"Pathol Int"},{"key":"key20250710122401_b35-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"key":"key20250710122401_b36-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00125480-200111000-00005","article-title":"RET oncogene activation in papillary thyroid carcinoma","volume":"8","author":"Tallini","year":"2001","journal-title":"Adv Anat Pathol"},{"key":"key20250710122401_b37-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1158\/1078-0432.CCR-08-2742","article-title":"Targeting the RET pathway in thyroid cancer","volume":"15","author":"Wells","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20250710122401_b38-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1158\/1078-0432.CCR-16-1679","article-title":"RET aberrations in diverse cancers: Next-generation sequencing of 4,871 patients","volume":"23","author":"Kato","year":"2017","journal-title":"Clin Cancer Res"},{"key":"key20250710122401_b39-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"175","DOI":"10.31662\/jmaj.2020-0021","article-title":"Roles of the RET proto-oncogene in cancer and development","volume":"3","author":"Takahashi","year":"2020","journal-title":"JMA J"},{"key":"key20250710122401_b40-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","article-title":"Papillary thyroid cancer: Genetic alterations and molecular biomarker investigations","volume":"16","author":"Abdullah","year":"2019","journal-title":"Int J Med Sci"},{"key":"key20250710122401_b41-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-20-3558","article-title":"FDA approval summary: Selpercatinib for the treatment of lung and thyroid cancers with RET gene mutations or fusions","volume":"27","author":"Bradford","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"932353","key":"key20250710122401_b42-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.932353","article-title":"RET signaling pathway and RET inhibitors in human cancer","volume":"12","author":"Regua","year":"2022","journal-title":"Front Oncol"},{"key":"key20250710122401_b43-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.trecan.2021.07.003","article-title":"Precision therapy for RET-altered cancers with RET inhibitors","volume":"7","author":"Thein","year":"2021","journal-title":"Trends Cancer"},{"key":"key20250710122401_b44-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"N Engl J Med"},{"key":"key20250710122401_b45-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion-positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"N Engl J Med"},{"key":"key20250710122401_b46-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc3680","article-title":"RET revisited: Expanding the oncogenic portfolio","volume":"14","author":"Mulligan","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"17588359221101691","key":"key20250710122401_b47-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221101691","article-title":"RET kinase inhibitors for RET-altered thyroid cancers","volume":"14","author":"Vodopivec","year":"2022","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"key20250710122401_b48-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2334\/josnusd.21-0154","article-title":"Clinical study of treatment methods and associated factors in mandibular osteoradionecrosis","volume":"63","author":"Hato","year":"2021","journal-title":"J Oral Sci"},{"key":"key20250710122401_b49-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ctrv.2015.11.003","article-title":"Lenvatinib: Role in thyroid cancer and other solid tumors","volume":"42","author":"Cabanillas","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"key20250710122401_b50-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-91442-8_13","article-title":"Lenvantinib: A tyrosine kinase inhibitor of VEGFR 1-3, FGFR 1-4, PDGFR\u03b1, KIT and RET","volume":"211","author":"Zsch\u00e4bitz","year":"2018","journal-title":"Recent Results Cancer Res"},{"issue":"48","key":"key20250710122401_b51-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-022-00219-8","article-title":"Bone remodeling: An operational process ensuring survival and bone mechanical competence","volume":"10","author":"Bolamperti","year":"2022","journal-title":"Bone Res"},{"key":"key20250710122401_b52-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2014.09.017","article-title":"Bringing new life to damaged bone: The importance of angiogenesis in bone repair and regeneration","volume":"70","author":"Stegen","year":"2015","journal-title":"Bone"},{"key":"key20250710122401_b53-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.ijom.2019.07.010","article-title":"Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib","volume":"48","author":"Mauceri","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key20250710122401_b54-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.4317\/jced.58323","article-title":"Photobiomodulation laser therapy in a lenvatinib-related osteonecrosis of the jaw: A case report","volume":"13","author":"Monteiro","year":"2021","journal-title":"J Clin Exp Dent"},{"key":"key20250710122401_b55-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10006-017-0667-5","article-title":"Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw","volume":"22","author":"Akashi","year":"2018","journal-title":"Oral Maxillofac Surg"},{"issue":"e00302","key":"key20250710122401_b56-ETM-30-2-12898","article-title":"Osteoradionecrosis of the jaw suspicious of correlation with bone-modifying agent treatment: A case report","volume":"5","author":"Kimura","year":"2024","journal-title":"Med Case Rep Stud Protoc"},{"key":"key20250710122401_b57-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"698","key":"key20250710122401_b58-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4612-2","article-title":"Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: A case report","volume":"18","author":"Tori","year":"2018","journal-title":"BMC Cancer"},{"issue":"e19408","key":"key20250710122401_b59-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019408","article-title":"Rapid disease progression after discontinuation of lenvatinib in thyroid cancer","volume":"99","author":"Yamazaki","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"81","key":"key20250710122401_b60-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2243","article-title":"Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer","volume":"14","author":"Toda","year":"2021","journal-title":"Mol Clin Oncol"},{"issue":"38","key":"key20250710122401_b61-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-023-01619-6","article-title":"Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: A case report","volume":"9","author":"Yamazaki","year":"2023","journal-title":"Surg Case Rep"},{"key":"key20250710122401_b62-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10637-014-0181-7","article-title":"Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas","volume":"33","author":"Dubbelman","year":"2015","journal-title":"Invest New Drugs"},{"key":"key20250710122401_b63-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/annonc\/mdx251","article-title":"Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding","volume":"28","author":"Resteghini","year":"2017","journal-title":"Ann Oncol"},{"key":"key20250710122401_b64-ETM-30-2-12898","author":"Tomlins"},{"key":"key20250710122401_b65-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/13696998.2023.2202599","article-title":"Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan","volume":"26","author":"Tang","year":"2023","journal-title":"J Med Econ"},{"key":"key20250710122401_b66-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.vhri.2023.08.006","article-title":"Cost-effectiveness of comprehensive genomic profiling in patients with non-small cell lung cancer for the colombian health system","volume":"39","author":"Gamboa","year":"2024","journal-title":"Value Health Reg Issues"},{"key":"key20250710122401_b67-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S2213-8587(21)00120-0","article-title":"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): A multi-cohort, open-label, registrational, phase 1\/2 study","volume":"9","author":"Subbiah","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20250710122401_b68-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1200\/JCO.23.02503","article-title":"Durability of response with selpercatinib in patients with RET-activated thyroid cancer: Long-term safety and efficacy from LIBRETTO-001","volume":"42","author":"Wirth","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1034","key":"key20250710122401_b69-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071034","article-title":"Understanding BRCA2 function as a tumor suppressor based on domain-specific activities in DNA damage responses","volume":"12","author":"Andreassen","year":"2021","journal-title":"Genes (Basel)"},{"issue":"92","key":"key20250710122401_b70-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00641-6","article-title":"BRD4: An effective target for organ fibrosis","volume":"12","author":"Wei","year":"2024","journal-title":"Biomark Res"},{"issue":"508","key":"key20250710122401_b71-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00433-7","article-title":"Tbx3-dependent amplifying stem cell progeny drives interfollicular epidermal expansion during pregnancy and regeneration","volume":"8","author":"Ichijo","year":"2017","journal-title":"Nat Commun"},{"key":"key20250710122401_b72-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"499e","DOI":"10.1097\/PRS.0000000000010286","article-title":"Sensory outcomes for inferior alveolar nerve reconstruction with allograft following free fibula mandible reconstruction","volume":"152","author":"Kaplan","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"1145","key":"key20250710122401_b73-ETM-30-2-12898","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19031145","article-title":"Oral factors as predictors of frailty in community-dwelling older people: A prospective cohort study","volume":"19","author":"Takeuchi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"key20250710122401_b74-ETM-30-2-12898","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.physbeh.2006.01.025","article-title":"Oral physiology and mastication","volume":"89","author":"van der Bilt","year":"2006","journal-title":"Physiol Behav"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:24:08Z","timestamp":1752139448000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.12898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5,29]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.12898","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}